Prostaglandins, cancer and bone: Pharmacological considerations
- 1 January 1980
- journal article
- other
- Published by Elsevier in Metabolic Bone Disease and Related Research
- Vol. 2 (3), 167-171
- https://doi.org/10.1016/0221-8747(80)90024-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Rat osteogenic sarcoma cells: Comparison of the effects of prostaglandins E1, E2, I2 (prostacyclin), 6-keto F1α and thromboxane B2 on cyclic AMP production and adenylate cyclase activityBiochemical and Biophysical Research Communications, 1978
- Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in cultureBritish Journal of Cancer, 1977
- PROSTAGLANDINS AND BREAST CANCERThe Lancet, 1977
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Rat osteogenic sarcoma cells: Effects of some prostaglandins, their metabolites and analogues on cyclic AMP productionProstaglandins, 1977
- Failure of indomethacin to reduce hydroxyproline excretion or hypercalcemia in patients with breast cancerProstaglandins, 1976
- Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcomaNature, 1976
- Indomethacin-Responsive HypercalcemiaNew England Journal of Medicine, 1975
- Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell AdenocarcinomaNew England Journal of Medicine, 1974
- Properties of human seminal plasmaThe Journal of Physiology, 1935